Literature DB >> 15763228

Morphology of alcoholic liver disease.

Jay H Lefkowitch1.   

Abstract

The major pathologic manifestations of alcoholic liver injury have been well described, and include three major lesions: steatosis (fatty liver), steatohepatitis (formerly alcoholic hepatitis), and cirrhosis. Recent attention to the problem of nonalcoholic fatty liver disease (NAFLD) in individuals with obesity, diabetes, and other risk factors has shed light on the mechanisms of cellular injury associated with hepatic steatosis and on the potential pathways to steatohepatitis and cirrhosis. Pathologists need to be familiar with the spectrum of changes seen in steatohepatitis, including hepatocyte ballooning, Mallory bodies, mixed inflammatory cell infiltrates, and a distinctive perivenular and pericellular "chicken-wire" fibrosis. These features and other less common histopathologic lesions in the liver are reviewed and illustrated.

Entities:  

Mesh:

Year:  2005        PMID: 15763228     DOI: 10.1016/j.cld.2004.11.001

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  57 in total

Review 1.  Histopathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

2.  A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma.

Authors:  Masato Fujii; Yuichiro Shibazaki; Kyoko Wakamatsu; Yutaka Honda; Yusuke Kawauchi; Kenji Suzuki; Somasundaram Arumugam; Kenichi Watanabe; Takafumi Ichida; Hitoshi Asakura; Hiroyuki Yoneyama
Journal:  Med Mol Morphol       Date:  2013-02-22       Impact factor: 2.309

3.  Hepatic fat assessment using advanced Magnetic Resonance Imaging.

Authors:  Yong Pang; Baiying Yu; Xiaoliang Zhang
Journal:  Quant Imaging Med Surg       Date:  2012-09

Review 4.  Severe alcoholic hepatitis-current concepts, diagnosis and treatment options.

Authors:  Won Kim; Dong Joon Kim
Journal:  World J Hepatol       Date:  2014-10-27

Review 5.  Pharmacotherapy of acute alcoholic hepatitis in clinical practice.

Authors:  Ludovico Abenavoli; Natasa Milic; Samir Rouabhia; Giovanni Addolorato
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 6.  Role of mitochondria in alcoholic liver disease.

Authors:  Fatiha Nassir; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 7.  Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis.

Authors:  Thomas Greuter; Harmeet Malhi; Gregory J Gores; Vijay H Shah
Journal:  JCI Insight       Date:  2017-09-07

Review 8.  Animal models for the study of liver fibrosis: new insights from knockout mouse models.

Authors:  Hiromitsu Hayashi; Takao Sakai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-24       Impact factor: 4.052

Review 9.  Alcoholic liver disease: pathogenesis and new targets for therapy.

Authors:  José Altamirano; Ramón Bataller
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-09       Impact factor: 46.802

10.  Alcoholic liver disease: a synopsis of the Charles Lieber's Memorial Symposia 2009-2012.

Authors:  Manuela G Neuman; Lawrence Cohen; Samir Zakhari; Radu M Nanau; Sebastian Mueller; Michelle Schneider; Charles Parry; Romina Isip; Helmut K Seitz
Journal:  Alcohol Alcohol       Date:  2014-05-09       Impact factor: 2.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.